000			01439 a2200421 4500
005			20250513175118.0
264		0	_c19990713
008			199907s 0 0 eng d
022			_a1053-4296
040			_aNLM _beng _cNLM
100	1		_aChoy, H
245	0	0	_aEsophagitis in combined modality therapy for locally advanced non-small cell lung cancer. _h[electronic resource]
260			_bSeminars in radiation oncology _cApr 1999
300			_a90-6 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Phytogenic _xadverse effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aEsophagitis _xetiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPaclitaxel _xadverse effects
650	0	4	_aProspective Studies
650	0	4	_aRadiotherapy _xadverse effects
650	0	4	_aSurvival Analysis
700	1		_aLaPorte, K
700	1		_aKnill-Selby, E
700	1		_aMohr, P
700	1		_aShyr, Y
773	0		_tSeminars in radiation oncology _gvol. 9 _gno. 2 Suppl 1 _gp. 90-6
999			_c10169803 _d10169803